Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |